
Stem Cell Network
@stemcellnetwork
SCN is a Canadian not-for-profit supporting stem cell and regenerative medicine research, training, and knowledge mobilization.
ID: 26487100
http://www.stemcellnetwork.ca 25-03-2009 12:39:35
9,9K Tweet
23,23K Followers
797 Following

Pleased to attend the Cancer Caucus & Parliamentary Health Research Caucus event yesterday, hosted by Research Canada and Canadian Cancer Society. What a powerful discussion on disruptive innovation in #CancerResearch, #ClinicalTrials, and their impact on patient outcomes.



The #SummerbyDesign deadline is approaching! The international program gives PhD students & post-docs the skills to commercialize #regenmed. Hosted by #MedicinebyDesign, CCRM, Stem Cell Network, Rotman School. Learn more & apply: mbd.utoronto.ca/opportunities/…



⏳ Time's running out to apply for #SummerByDesign 2025! PhD students & postdocs in #RegenMed will: 🔬 Explore pathways from lab to impact 🌟 Learn commercialization & career options 🤝 Network with industry leaders 📅 June 2–11, 2025 📍University of Toronto 🔗 mbd.utoronto.ca/opportunities/…






Ready to advance Type 1 Diabetes research? The Andrew McKee Fellowship at University of British Columbia's Breakthrough T1D Centre of Excellence is open for applications! All post-docs are invited to apply for this opportunity. 🌐 ➡️ stemcellnetwork.ca/training/excha…



Planning to apply for the J. Andrew McKee Fellowship? The notice of intent is due on Jan 30, 2025! Supported by SCN and Breakthrough T1D Canada (formerly JDRF), this is your chance to join University of British Columbia’s Breakthrough T1D Centre of Excellence. Submit your application here. ➡️ stemcellnetwork.ca/training/excha…


Application period extended to Jan. 20! Apply to participate in this program that gives PhD students & post-docs a foundation in the commercialization & business aspects of #regenmed. Hosted by #MedicinebyDesign with partners CCRM, Stem Cell Network & Rotman School.

Congrats to Aspect Biosystems on closing their US$115M Series B round! 👏 This milestone will accelerate bioprinted tissue therapeutics, advancing treatments for serious diseases. Shoutout to Tamer Mohamed, Founder & CEO of Aspect Biosystems and Board Member of SCN, and the entire team!